Axtria Thought Leadership

Executive insights and perspectives on the Life Sciences industry

Clinical Trials


The Power Of Digital Technologies In Transforming Clinical Trials

Clinical trials are becoming more complex as pharmaceutical companies focus their research and development efforts on treatments for rare diseases and personalized medicine, and on ...

COVID-19 Recession Effects on Pharmaceutical Patient Health Outcomes

White Paper

COVID-19 Recession Effects On Pharmaceutical-Related Patient Health Outcomes

This white paper investigates the research framework to model the expected effects on the decline in health outcomes caused by a decrease in the quantity and quality of pharmaceuti ...

Pharma Incentive Compensation

White paper

Should Pharmaceutical Incentive Compensation Plans Cap At-Risk Sales Rep Compensation?

This white paper looks at a simple but important research question – why do pharma companies have incentive compensation (IC) plans that cap their at-risk sales rep compensation? ...

Coronavirus Pandemic Effects On Incentive Compensation

White Paper

Coronavirus Pandemic Effects On Incentive Compensation

This paper focuses on coronavirus pandemic effects on IC for pharma companies in the short-term, medium-term, and long-term, while also providing prescriptive actions for sales exe ...

Patient-Centric Commercial Strategy

White Paper

Designing A Patient-Centric Commercial Strategy

This whitepaper addresses how RWE should be leveraged for informing various commercial decisions with a deeper-dive into marketing-mix analysis (MMx). ...

Coronavirus Pandemic US Pharmaceutical Industry

White Paper

How Will The Coronavirus Pandemic Affect The US Pharmaceutical Industry?

The outbreak of the coronavirus pandemic illustrates the inherent risks and uncertainties that are prevalent in the operation of complex and global business, as seen in the pharmac ...

Corona Virus White Paper

White Paper

Can The Coronavirus Contagion Economically Infect The Global Pharmaceutical Industry?

Events surrounding the coronavirus contagion, characterized as a “black swan” event, which started in China, remain very fluid and are changing daily. No one really knows what ...

Call Plan Adherence

White Paper

What Are The Factors That Cause Call Plan Adherence To Fail And How To Address The Problem

The sales force for a pharma company still represents one of the largest line items in the budget and is the most significant driver of sales relative to all other individual sales ...

One Important Lesson From Biogen’s Surprise Announcement On Hopes For An Alzheimer’s Drug: A Commentary

White Paper

One Important Lesson From Biogen’s Surprise Announcement On Hopes For An Alzheimer’s Drug

This white paper lays out the reasons for these changes and action steps executives must make to shift from the current volume-based to value/outcomes-based commercial model design ...

Start typing and press Enter to search